These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 19059054

  • 1. The deleterious effects of iron overload in patients with myelodysplastic syndromes.
    Dreyfus F.
    Blood Rev; 2008 Dec; 22 Suppl 2():S29-34. PubMed ID: 19059054
    [Abstract] [Full Text] [Related]

  • 2. Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload.
    Gattermann N.
    Leuk Res; 2007 Dec; 31 Suppl 3():S10-5. PubMed ID: 18037413
    [Abstract] [Full Text] [Related]

  • 3. Impact of iron overload in myelodysplastic syndromes.
    Fenaux P, Rose C.
    Blood Rev; 2009 Dec; 23 Suppl 1():S15-9. PubMed ID: 20116635
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes.
    Jabbour E, Kantarjian HM, Koller C, Taher A.
    Cancer; 2008 Mar 01; 112(5):1089-95. PubMed ID: 18186499
    [Abstract] [Full Text] [Related]

  • 10. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions.
    Chacko J, Pennell DJ, Tanner MA, Hamblin TJ, Wonke B, Levy T, Thomas PW, Killick SB.
    Br J Haematol; 2007 Sep 01; 138(5):587-93. PubMed ID: 17610536
    [Abstract] [Full Text] [Related]

  • 11. Red blood cell transfusion therapy and iron chelation in patients with myelodysplastic syndromes.
    Malcovati L.
    Clin Lymphoma Myeloma; 2009 Sep 01; 9 Suppl 3():S305-11. PubMed ID: 19778858
    [Abstract] [Full Text] [Related]

  • 12. Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes.
    Delforge M, Selleslag D, Beguin Y, Triffet A, Mineur P, Theunissen K, Graux C, Trullemans F, Boulet D, Van Eygen K, Noens L, Van Steenweghen S, Lemmens J, Pierre P, D'hondt R, Ferrant A, Deeren D, Van De Velde A, Wynendaele W, André M, De Bock R, Efira A, Breems D, Deweweire A, Geldhof K, Pluymers W, Harrington A, MacDonald K, Abraham I, Ravoet C.
    Leuk Res; 2014 May 01; 38(5):557-63. PubMed ID: 24661630
    [Abstract] [Full Text] [Related]

  • 13. Iron overload in MDS-pathophysiology, diagnosis, and complications.
    Gattermann N, Rachmilewitz EA.
    Ann Hematol; 2011 Jan 01; 90(1):1-10. PubMed ID: 20938663
    [Abstract] [Full Text] [Related]

  • 14. Understanding iron overload: screening, monitoring, and caring for patients with transfusion-dependent anemias.
    Ault P, Jones K.
    Clin J Oncol Nurs; 2009 Oct 01; 13(5):511-7. PubMed ID: 19793708
    [Abstract] [Full Text] [Related]

  • 15. Improved survival in MDS patients receiving iron chelation therapy - a matched pair analysis of 188 patients from the Düsseldorf MDS registry.
    Neukirchen J, Fox F, Kündgen A, Nachtkamp K, Strupp C, Haas R, Germing U, Gattermann N.
    Leuk Res; 2012 Aug 01; 36(8):1067-70. PubMed ID: 22564985
    [Abstract] [Full Text] [Related]

  • 16. Iron overload and chelation therapy in myelodysplastic syndromes.
    Temraz S, Santini V, Musallam K, Taher A.
    Crit Rev Oncol Hematol; 2014 Jul 01; 91(1):64-73. PubMed ID: 24529413
    [Abstract] [Full Text] [Related]

  • 17. Management of transfusion-related iron overload in patients with myelodysplastic syndromes.
    Shah J, Kurtin SE, Arnold L, Lindroos-Kolqvist P, Tinsley S.
    Clin J Oncol Nurs; 2012 Jun 01; 16 Suppl():37-46. PubMed ID: 22641283
    [Abstract] [Full Text] [Related]

  • 18. Iron chelation therapy in MDS: what have we learnt recently?
    Schmid M.
    Blood Rev; 2009 Dec 01; 23 Suppl 1():S21-5. PubMed ID: 20116636
    [Abstract] [Full Text] [Related]

  • 19. Iron chelation therapy for patients with myelodysplastic syndrome.
    Yeh SP, Yang YS, Yao CY, Peng CT.
    Hemoglobin; 2009 Dec 01; 33(5):339-45. PubMed ID: 19814680
    [Abstract] [Full Text] [Related]

  • 20. Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes.
    Malcovati L.
    Leuk Res; 2007 Dec 01; 31 Suppl 3():S2-6. PubMed ID: 18037415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.